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Abstract 
 
Background: Shared decision making is advocated, but may be affected by cognitive 
impairment. Measures of shared decision making provide global descriptions 
of communication without detailed analysis of the subtle ways in which doctors invite 
patient input.  
 
Aims: To explore medication decisions in dementia using a standardised Treatment 
Recommendation Coding Scheme. 
 
Methods: 71 video recorded dementia diagnostic meetings from 9 memory clinics were 
coded. Doctors recommended treatment using 5 different formats: pronouncements (“I will 
start you on medication”), proposals (“shall we try medication?”), suggestions (“would you 
like to try medication?”), offers (“I can prescribe medication”), and assertions (“there is 
medication”). Patient responses were coded as acceptance (“I’d like to have that”), active 
resistance (“I’m not very keen”), and passive resistance (minimal or no response). Cognitive 
test scores, prescription rates, and satisfaction were assessed and associations explored.  
  
Results: Doctors used suggestions in 42% of meetings, proposals in 25%, assertions in 13%, 
pronouncements in 11%, and offers in 9%. Over 80% of patients did not indicate clear 
acceptance. Patients were most likely to actively resist after suggestions. There was no 
association between cognitive impairment and recommendation format. Patients were less 
satisfied with pronouncements. Patient preference did not influence whether medication 
was prescribed.  
  
Conclusions: Doctors in memory clinics initially nominate patients as the decision maker, 
and this is not affected by cognitive impairment. Although over 80% of patients resisted the 
option of starting medication, medication still tended to be prescribed, indicating factors 
other than patient preference affect prescription.   
 
Declarations of Interest: None 
 
  
  
Introduction  
Involving patients in decisions about their psychiatric treatment has been shown to increase 
patient satisfaction, treatment adherence and improve clinical outcomes (1). There has 
been little research observing how doctors communicate with people with dementia when 
making decisions about anti-dementia medication (2), but there is an indication that shared 
decision making may be low (3). The inherent cognitive impairment of dementia, alongside 
the increasing role of family, has been shown to impact on patient involvement (4). 
However, people with dementia, like other illnesses, want to be involved in discussions 
about their care (5). 
 
Most research on shared decision making has used scales which offer a global picture of 
patient involvement, such as whether doctors ask patient preferences or list options (6, 7). 
However, analysis of how, rather than whether, doctors discuss medication with patients is 
vital for a more nuanced understanding. How doctors recommend treatment is particularly 
vital: it is at this point that the patient is identified either as the primary decision maker or a 
passive party (8). Recently, a novel approach examining how doctors format treatment 
recommendations in more or less authoritative ways has been developed (9). As Stivers and 
colleagues point out, there are clear differences between “I'm going to start you on X”, “We 
can give you X to try” and “Would you like me to give you X”. As these different formats are 
more or less authoritative, they afford patients different degrees of autonomy to decide 
whether or not to accept or resist treatment recommendations. Furthermore, just as 
medication recommendations are subtly different, subtle differences in patient responses 
indicate either acceptance or resistance. A well-established body of studies on agreement 
and disagreement in interaction have shown that acceptance occurs quickly and positively, 
and resistance can be passive or active (10-12). Passive resistance involves a delayed 
response, withheld response, or a minimal verbal (e.g. mhm) or non-verbal response (a 
nod), while active resistance involves explicit statements of non-agreement or questioning 
the recommendation (10).  
 
The aim of this study was to analyse how doctors involve patients with cognitive impairment 
in decisions to start medication, and whether this has an effect on patient acceptance of 
medication. Associations with patient cognitive functioning, satisfaction, and prescription 
were also explored.  
 
Materials and Methods  
Camden and Islington National Research Ethics Committee approved the project 
(13/LO/1309). The data was collected as part of the NIHR RfPB funded Shared decision 
making in mild to moderate Dementia study (ShareD - PB-PG-1111-26063). This was an 
observational study collecting video recordings from routine memory clinic diagnostic 
feedback appointments where patients were told whether or not they had dementia. 
Recruitment was conducted in two sites in the UK – London (urban) and Devon (rural). In 
London, there were six participating memory clinics across three NHS trusts. In Devon, there 
were three participating memory clinics within one NHS trust. Recruitment ran from May 
2014 to July 2016. 
 
Recruitment 
We approached all clinicians delivering dementia diagnoses in the participating trusts. The 
aim was to recruit all consecutive patients attending the memory clinic for diagnosis 
feedback, except for those needing interpreters due to the added complexity of the 
communication. Administrative staff sent information sheets with patient appointment 
letters. Clinicians assessed whether patients had capacity to provide informed consent, and 
researchers approached patients and their companions to discuss the study. Two patients in 
this study were judged not to have capacity, and in these cases we followed the Department 
of Health guidance on nominating a consultee for research involving adults who lack 
capacity to consent (13) .  
 
Data Collection 
 
Treatment Recommendations and Responses 
We filmed patients’ meetings with their clinician using GoPro cameras without the 
researcher present. The meetings were transcribed verbatim and medication discussions 
identified. Detailed, conversation analytic transcription methods were used for the excerpts 
of the meeting containing treatment recommendations and responses to illustrate 
characteristics of speech such as pauses, overlap, stress, intonation, and pace (14). For 
clarity, these symbols have been removed where extracts and quotes have been presented 
in this paper but are available from the authors on request. 
 
Patient capacity  
Patient capacity to make decisions about medication was recorded by clinicians after the 
meeting. Capacity was recorded as full, partial or no capacity. 
 
Cognitive test score 
Cognitive functioning was assessed by clinicians using the ACE-III (15) or MMSE cognitive 
test (16) as part of usual practice. 
 
Patient satisfaction 
After the meeting the patient completed the Patient Experience Questionnaire (PEQ) (17). 
The communication subscale of the PEQ was used to obtain communication-specific 
satisfaction ratings. This subscale contains 4 statements (“we had a good talk”; “I felt 
reassured”; “the doctor understood what was on my mind” and “I felt I was taken care of”) 
each with a 5 point Likert scale from “Agree completely” to “Disagree completely”. The total 
possible score is 20. 
 
Prescription outcome 
Whether medication was prescribed or not was identified from the recordings. The reason 
for not prescribing medication was recorded. 
 
Data Analysis 
 
Treatment recommendation 
Each recommendation was coded using the “Treatment Recommendation Coding Scheme” 
(9), which was developed in US and UK primary care, and in UK psychiatry and neurology 
settings. The coding scheme was comprehensively developed using conversation analytic 
methods that examined inductively how treatment recommendations are made in practice.  
 
The coding scheme includes 5 recommendation formats as follows:  
1. Pronouncements – patients are given no choice, e.g. “I will start you on medication” 
2. Proposals – patients are invited to endorse or collaborate with the doctor’s idea, e.g. 
“How about trying medication?” 
3. Suggestions – medication is endorsed by doctors but patients are given the choice, 
e.g. “Would you like to try medication?” 
4. Offers – doctors show a willingness to prescribe for the patient, but do not actively 
endorse medication, e.g. “Do you want me to give you medication?” 
5. Assertions – doctors state the fact that medication exists without endorsement or 
explicit recommendation, e.g. “There is a medication”. 
 
Patient Responses 
Using the coding scheme, the patient response was coded as: 
1. Acceptance – quick positive acceptance, e.g. “I’d like to have that”. 
2. Passive resistance – minimal verbal or non-verbal acknowledgment, e.g. “mhm” or 
nodding, or no response. 
3. Active resistance – questioning the purpose of medication or indicating a wish not to 
take the medication, e.g. “I’m not very keen, I don’t want to take more tablets”. 
 
Two researchers coded all the recommendation formats and patient responses and 
discrepancies were resolved through discussion.  
 
Relationships between treatment recommendation, patient acceptance or resistance, and 
whether medication was prescribed were explored using Fischer’s exact tests. Possible 
associations between recommendation format and patient acceptance or resistance, 
cognitive test score, and patient satisfaction were explored using ANOVA. The authors were 
not blinded to these factors when conducting the coding and analysis.  
 
Results  
The consent rate for clinicians in the study was 88%. Of the 215 patient participants 
(consent rate 51%), 101 were diagnosed with dementia. Of the 101 video recorded 
meetings where patients received a diagnosis of dementia, 71 were included (Figure 1). In 
the remaining 30 recordings there were 6 cases of equipment malfunction, 18 vascular 
dementia diagnoses where medication was not offered, and 1 semantic dementia diagnosis 
where medication was not offered. In 5 Alzheimer’s disease cases medication was not 
recommended: either medication was not discussed at all, or it was discussed but not 
presented as an option. 
  
  
 
Figure 1: Patient flow diagram 
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Participant Characteristics 
Participant characteristics are displayed in Table 1. There were 71 patients, 67 companions, 
and 21 doctors. Most patients were white, receiving a diagnosis of Alzheimer’s disease or 
mixed dementia. Nearly two thirds were female. Where doctor judgement of patient 
capacity to make medication decisions was recorded, 70% had full and 22% partial capacity. 
Companions were present in most meetings and were nearly always spouses/partners or 
children/children in law. Doctors were primarily psychiatrists, with 3 geriatricians.  
  
 Table 1: Participant Characteristics 
Site (n, %) 
London 
Devon 
 
30 (42%) 
41 (58%) 
Patient sex (n, %) 
Female 
 
44 (62%) 
Patient Age (mean, range) 81 (65-91) 
Patient Ethnicity (n, %) 
White British/Irish 
White Other 
Caribbean  
Black or Black British 
African 
Other 
Missing 
 
59 (82%) 
3 (4%) 
3 (4%) 
1 (2%) 
1 (2%) 
2 (3%) 
2 (3%) 
Patient Diagnosis (n, %) 
Alzheimer’s disease 
Mixed dementia 
Dementia unspecified 
Parkinson’s disease 
Lewy body dementia 
 
49 (69%) 
14 (20%) 
4 (5%) 
2 (3%) 
2 (3%) 
Patient Cognitive Test Score (mean, range) 
ACE-III (n=58) 
MMSE (n=11) 
 
69 (41-94) 
23 (15-28) 
Patient Capacity to make Decision about 
Medication (Judged by doctor) (n, %) 
Full 
Partial 
None 
Missing 
 
 
43 (61%) 
16 (22%) 
3 (4%) 
9 (13%) 
  
Companion Present (n, %) 67 (94%) 
Companion Type (n, %) 
Spouse/partner 
Child/child in law 
Sibling 
Friend 
Other 
Missing 
 
27 (40%) 
27 (40%) 
2 (3%) 
2 (3%) 
8 (12%) 
1 (2%) 
  
Professional Type (n, %) 
Consultant Psychiatrist 
Consultant Geriatrician 
Specialty Doctor 
 
15 (71%) 
3 (14%) 
3 (15%) 
Professional number of years working in 
dementia (mean, range) 
 
12 (1-25) 
Professional Gender (n, %) 
Female 
 
11 (52%) 
Ethnicity (n, %) 
White British 
White Other 
Asian or Asian British 
Indian 
 
14 (66%) 
3 (14%) 
2 (10%) 
2 (10%) 
 
 
  
Treatment Recommendation Formats and Responses 
 
Treatment Recommendation Formats 
Doctors primarily formatted treatment recommendations in a way that nominated the 
patient as primary decision maker. In 73% of treatment discussions, doctors initiated the 
discussion with assertions, i.e. a general statement about the existence of medication such 
as “there are medications we can try”. These preliminary statements usually either 
contained a reference to the tablets not being a cure and/or a description of side effects. In 
the majority of meetings where discussions started with assertions, these assertions were 
treated as information giving: there was little response from patients and doctors quickly 
moved on to the treatment recommendation proper. Extract 1 is an example of this:  
 
Extract 1: 
1 DR:  now (0.6) there is some medication (.) that (0.3) many  
2      people take (.) to help with the symptoms of memory loss 
3      (0.5) 
4 DR:  and about two thirds of people find it gives them some 
5      benefit  
6      (0.4) 
7 DR:  uhm some people most people don’t but some people get some  
8      side effects such as a little bit of nausea or a loose stool  
9      or a headache or or a feeling of dizziness 
10      (0.6) 
11 DR:  would you like to think about taking some medication 
12      (0.6) 
13 PT:  yes well (0.9) see how it goes I’ve got a lot of  
14      medication I take almost every day 
 
The doctor asserts that there is “some medication” to help memory loss in lines 1-2, 
followed by the caveats that not all people will benefit (lines 4-5) and that “some people get 
some side effects” (lines 7-9). This is followed by a suggestion in line 11, where the doctor 
nominates the patient as the decision maker: “would you like to think about taking some 
medication”. 
 
Suggestions, as in Extract 1, were used in 42% of meetings. Proposals were used in 25% 
meetings (“we could try you on a tablet to help contain or maintain or make this stable in 
the future”), pronouncements in 11% of meetings (“I would want you to start at least taking 
medication”) and offers in 9% meetings (“the other thing we can do is to give you a tablet if 
you would like”).  Assertions were used as the only treatment recommendation type in 13% 
(“there is now medications that we can offer people”).  
 
Patient Responses 
Forty-five patients (63%) passively resisted medication by responding minimally (e.g. 
“mhm”), nodding, or not responding. 13 patients (18.5%) actively resisted medication (“is it 
going to help, I take medication already”), and 13 patients (18.5%) explicitly accepted 
medication (“yes I’ll take them”).  
 
Association between recommendation format and patient response  
There was a significant association between recommendation format and patient response 
(Fisher’s Exact Test: p=0.014). Patients only actively resisted medication after suggestions or 
proposals, and always passively resisted pronouncements (see Table 2). Just over half the 
time that patients accepted medication, doctors had used proposals.  
  
 Table 2: Treatment Recommendation, Response, and Prescription Outcomes 
 Acceptance Passive 
Resistance 
Active 
Resistance Total 
Pronouncement 0 8 0 8 
Proposal 7 9 2 18 
Suggestion 3 16 11 30 
Offer 1 5 0 6 
Assertion 2 7 0 9 
Total 13 45 13 71 
Prescribed 9 36 9 54 
Not Prescribed 4 9 4 17 
 
 
  
Recommendation format and cognitive test score 
There was no association between recommendation format and the patient’s level of 
cognitive impairment as shown on the ACE-III (F(4,53) = .478, p = .751) or MMSE (F(3,7) = 
.557, p = .660).  
 
 
Recommendation format and patient satisfaction 
Patients were significantly less satisfied with the communication when they were not 
offered a choice in taking medication, i.e., when pronouncements were used (14.3/20) 
compared to other recommendation formats (16.5-17.3/20) (F(4,59) = 3.047, p = .024).  
 
 
Patient response and prescription outcomes 
Medication was prescribed in 76% (n=54) of the meetings. There was no association 
between patient acceptance or resistance and whether medication was prescribed (Fisher’s 
Exact Test, p=.561). Medication was just as often prescribed when patients resisted as when 
they accepted (see Table 2).  
 
In the 17 cases where medication was not prescribed, 9 (53%) decisions were deferred for 
further investigation, either an ECG or referral to neurology. In 4 cases (24%) patients 
expressed a wish to talk to family or their GP before making a decision, and in 2 cases 
(11.5%) there was a joint decision not to take medication. In the remaining 2 cases (11.5%) 
the doctor decided to defer the decision until support was in place from the community 
mental health team. 
 
 
Discussion  
 
Doctors in memory clinics overwhelmingly nominated patients as the decision maker when 
starting medication for dementia. Over 80% of patients appeared to show some reluctance 
to start medication, primarily through passive resistance. However, medication still tended 
to be prescribed. 
 The use of assertions to initiate medication discussions has also been described in neurology 
(18). Assertions are poised between informing the patient about medication and 
recommending medication to the patient. This places very little interactional pressure on 
the patient for an immediate decision, thus allowing for further discussion. Toerien 
describes assertions as ‘cautious recommendations’ in environments of diagnostic 
uncertainty, likely patient resistance, and uncertain efficacy of the mediation (18). In 
memory clinics, patients will be dealing with a life-changing diagnosis of dementia. The use 
of assertions prior to an explicit recommendation may therefore facilitate a smoother, more 
sensitive transition between the diagnosis and decision making about treatment.  
  
Doctors used fewer pronouncements than in primary care (65% US, 45% UK) (9) and general 
psychiatry (25%) (19). This suggests a higher willingness to include patients in medication 
decisions at dementia diagnosis. Indeed, two thirds of treatment recommendations were 
suggestions or proposals, demonstrating that doctors endorse medication as a treatment 
option but are encouraging patient participation in the decision. However, subtle 
differences in the precise formulation of the recommendation have an effect on patient 
response. With proposals, doctors are inviting patients to join in with their endorsement of 
medication. With suggestions, doctors are inviting the patient to decide whether they would 
like to start medication (9).  This has important consequences for how patients respond: 
proposals led to higher levels of acceptance whereas suggestions led to higher levels of 
resistance. This demonstrates how subtly different formats create different possibilities for 
patient choice and participation in decision making.  
 
The majority of patients appeared to show some reluctance to start medication. However, 
previous work on resistance to treatment recommendations has been done with cognitively 
intact patients in primary care and patients with psychosis in outpatient psychiatric care. It 
may be that passive resistance – a non-verbal response or a minimal verbal response – in 
cognitively intact patients does not indicate passive resistance in people who are cognitively 
impaired. For example, there is evidence that reaction times in conversation can be 5 times 
slower for people with moderate dementia than people without dementia (20). Therefore, 
people with dementia may be responding more slowly when withholding a response rather 
than resisting. Conversely, people with dementia have also been found to agree more in 
conversation, suggesting an attempt to remain engaged in the interaction, through assent, 
rather than actual agreement (21). 
 
Although marginalisation of people with dementia has been described in previous studies 
(2, 22, 23), doctors involved patients in decisions irrespective of cognitive impairment. This 
is a positive finding demonstrating that doctors in UK memory clinics are not excluding 
patients with lower cognitive test scores from decisions about their medication, and in line 
with patients’ preferences to be involved in decision making (4, 5). However, the majority of 
patients in this study were in the mild to moderate stages of dementia and decision making 
with people in later stages may be different.  
 
Patients were significantly less satisfied with communication when they are not offered a 
choice (“I’ll start you on medication”), illustrating that patients detect subtle differences in 
communication. This is in line with other studies of shared decision making (24) and 
demonstrates the importance of including people with dementia in decisions. It must 
however be noted that patients were rating their satisfaction with communication in the 
meeting as a whole, and there could be other communication difficulties affecting patient 
experience and potentially causing doctors to use pronouncements when it came to 
recommending medication.  
 
Patients’ acceptance or resistance of medication did not influence whether medication was 
prescribed. In 69% of cases where patients actively resisted medication (9/13), it was 
nonetheless prescribed. If medication was not prescribed, this was usually due to a need for 
further investigation (ECG or neurology) or doctors planning to put other support in place 
first, further indicating the doctor’s authority in the outcome of medication decisions. 
However, there are other factors which are likely to come into play here. In this study, 8% of 
patients were judged not to have capacity to make medication decisions and 22% were 
judged to have partial capacity. Moreover, doctors report wishing to offer medication to 
instil hope after breaking bad diagnostic news, and therefore may find it difficult not to 
prescribe medication (25). Family preferences may also come into play: doctors have been 
shown to invite family involvement in medication discussions more than in other parts of 
the consultation (26), and caregivers deem medication to be important for access to 
services and to provide hope for the future (27).  However, it is worth noting that only the 
patient’s initial response to the treatment recommendation was taken into account in this 
analysis, and it may be that they would have changed their minds after further discussion. 
 
Strengths and Limitations 
The strength of this study was the systematic, standardised analysis of treatment 
recommendations, using a novel approach to capture more subtle aspects of shared 
decision making. This is relevant both to old age psychiatry and other areas of psychiatry 
where patients may experience cognitive impairment such as schizophrenia or intellectual 
disabilities. This study is the first to use this detailed method to examine decision making 
when people receive a diagnosis of dementia, and includes a range of patients, doctors, and 
clinics. However, doctors knew they were being filmed and this may have affected their 
behaviour. The researchers who coded the transcripts and conducted the analysis were not 
blinded, which may add bias. Companion behaviour was not analysed, which may have 
impacted on decision making. Additionally, the majority of the patient were white, and 
consultations using an interpreter were not included, which limits generalisability.  
 
Conclusions 
Doctors included patients with cognitive impairment in decisions about starting medication 
after receiving a diagnosis of dementia. Most often, they nominated the patient as the 
primary decision maker. This allowed patients to resist, with over 80% appearing to show 
some reluctance towards starting medication. Medication still tended to be prescribed, 
suggesting factors such as patient capacity, doctors’ wishing to offer hope and companion 
involvement are also important in decisions to start medication. 
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